Life ScienceCompany
Dermapharm Holding M&A Summary
Dermapharm Holding has acquired 3 companies, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms.
Dermapharm Holding’s largest acquisition to date was in 2021, when it acquired C³ Cannabinoid Compound Company for $138M. Dermapharm Holding has acquired in 3 countries. The Company’s most targeted sectors include life science (100%).
Dermapharm Holding Business Overview
Where is Dermapharm Holding headquartered?
Dermapharm Holding is headquartered in Grunwald, Germany.
What is Dermapharm Holding’s revenue?
Dermapharm Holding disclosed revenue of 1,135M EUR for 2023 and 1,025M EUR for 2022.
How many employees does Dermapharm Holding have?
Dermapharm Holding has 3,497 employees.
What sector is Dermapharm Holding in?
Dermapharm Holding is a life science company.
When was Dermapharm Holding founded?
Dermapharm Holding was founded in 1991.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 3
- M&A Advisors 3